Frederic Kerrest
Co-Founder @ System1 Biosciences
San Francisco, United States
Frederic Kerrest is a Series A investor at System1 Biosciences in San Francisco focused on Software and SaaS. Frederic Kerrest is the Chief Operating Officer and Co-Founder of Okta. He is responsible for Okta’s day-to-day operations, working with employees, partners and customers to deliver on the company’s mission of leveraging the cloud to make people more productive and IT more secure. As a key member of management, Frederic helps set corporatepriorities to drive success for the company and its customers.Frederic is passionate about enterprise technology and has spent almost two decades driving corporate efficiency via innovative software solutions. Prior to co-founding Okta, he worked at Hummer Winblad Venture Partners, where he evaluated enterprise software investment opportunities and helped portfolio companies strengthen their operations and Go-To-Market strategies. From 2002 to 2007, Frederic worked in sales and business development at Salesforce.com, where he started and built the Latin America sales organization, Mobile group and OEM / Reseller programs and was a two-time Peak Performer Sales Award recipient. Prior to Salesforce.com, he co-founded and served as director of technology at an award-winning high-tech consulting firm. Frederic began his career in a variety of enterprise software development and management roles.Frederic earned a French Baccalauréat (Sciences) from the Lycée International de St. Germain-en-Laye in France, a BS in Computer Science from Stanford University, and an MBA in Entrepreneurship & Innovation from the MIT Sloan School of Management, where he was the 2008 MIT Patrick J. McGovern, Jr. Entrepreneurship Award recipient. Frederic currently serves as an advisor to early stage software companies and a mentor at the MIT Trust Center for Entrepreneurship and the Stanford StartX Accelerator program. He enjoys spending time with his wife and son, reading historical biographies, playing ice hockey and supporting the San Jose Sharks.
- Total investments:
- 56
- Last investment:
- Lead investor:
- 2%
Last updated:
For AI agents: llms.txt
Industries Frederic Kerrest invests in
Stages Frederic Kerrest invests in
Countries Frederic Kerrest invests in
Round sizes
Round size
- Seed
- $3M–$12M
- Series A
- $14M–$37M
- Series B
- $16M–$60M
Investment Focus
Industry
- Software 23 (41%)
- SaaS 11 (20%)
- Information Technology 10 (18%)
- Artificial Intelligence 10 (18%)
- Machine Learning 8 (14%)
Stage
- Series A 18 (32%)
- Seed 17 (30%)
- Series B 8 (14%)
- Funding Round 5 (9%)
- Series C 3 (5%)
Country
- United States 41 (73%)
- Canada 1 (2%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
JetStream Security
|
JetStream Security is a platform for enterprise AI governance and security designed to manage, safeguard, and expand agentic AI in manufacturing. JetStream allows teams to define and approve AI behavior, ties all actions together, and offers continuous AI visibility across models, agents, copilots, tools, and processes. | $34M / Seed / Mar 03, 2026 | |
Datalinx AI
|
Datalinx AI is an agentic software application that prepares consumer data for AI models and applications quickly and securely. | $4.2M / Seed / Jan 29, 2026 | |
Method Security
|
Method Security develops autonomous cyber defenses. | $21.5M / Series A / Nov 19, 2025 | |
Kadence
|
Kadence is the world’s #1 workplace operations platform for people and spaces. Designed for modern enterprises, Kadence unifies space management, team scheduling, occupancy insights, and AI-powered coordination into one seamless platform. Organizations around the world use Kadence to lower real estate costs, increase employee engagement, and drivebetter business outcomes. Trusted by leading global companies, Kadence empowers teams to work with purpose and operate at peak performance in today’s flexible work environment. | $20M / Series A / Jul 22, 2025 | |
Actively AI
|
Founded by Stanford AI researchers, Actively AI helps GTM teams 2x pipeline through AI-powered prioritization and personalization. | $17.5M / Series A / Apr 02, 2025 | |
Actively
|
A seamless booking assistant for your favorite fitness classes & wellness experiences | $17.5M / Series A / Apr 02, 2025 | |
dweva.com
|
System Two Security offers a platform that combines AI agents and assistants to support detection engineering teams in processing intelligence, creating new detections, and managing detection libraries. The system enables users to draft and refine detections based on threat intelligence and coverage gaps. | $7M / Venture - Series Unknown / Dec 04, 2024 | |
Promptfoo
|
Promptfoo finds & fixes LLM vulnerabilities before they are shipped to production. Its founders launched and scaled AI at Discord to 200M users using new research techniques specific to AI vulnerabilities and red-teaming. Promptfoo is open-source and is the most widely adopted tool in this space, with over 25,000 users at companies likeShopify, Amazon, and Anthropic. | $5M / Seed / Jul 23, 2024 | |
Noded Ai
|
Noded Ai is preparing yourself for that customer meeting is tough. Noded brings them all together using your notes history and gives you exactly what you needed , when you need it. So you’re always prepared and one step ahead. | $4M / Seed / Jul 22, 2024 | |
Pelotero
|
Pelotero is a pioneering player intelligence platform that integrates data, coaching expertise, and AI to empower coaches in delivering real-time, personalized development. The product offers customized analysis, instructional guidance, and development strategies tailored specifically for baseball hitters. Pelotero is committed to unlocking eachplayer's maximum potential by converting data into actionable insights, effectively bridging the gap to peak performance. | $3M / Seed / Jul 18, 2024 | |
| See all 56 investments → | |||
Co-Investors
About System1 Biosciences
System1 Biosciences, Inc., is a San Francisco-based neurotherapeutics company that employs phenotypic screening to discover novel drugs for complex neurological and psychiatric diseases such as epilepsy, autism, and schizophrenia, disorders for which current discovery techniques have proved least successful. System1 combines cerebral organoidscience, systems neuroscience, robotic automation, and advanced data analytics to discover characterizations of disease never before achievable. These “deep phenotypes” are exploited to identify novel therapeutic targets and drug treatments.
System1 Biosciences Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Frederic Kerrest
Co-Founder
|
|||
Sean Escola
Co-Founder
|
|||
3 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Frederic Kerrest invest in?
Frederic Kerrest invests primarily in Software, SaaS and Information Technology startups, most often at Series A and Seed stage. Most of the 56 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Frederic Kerrest's check size?
Frederic Kerrest typically joins rounds of $3M–$12M at Seed, $14M–$37M at Series A and $16M–$60M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Frederic Kerrest participates in.
When did Frederic Kerrest last invest?
The most recent investment recorded for Frederic Kerrest closed in Mar 2026. Shizune tracks 56 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
